250 results
Page 3 of 13
8-K
EX-99.1
sjnw g4zjg59c
28 Sep 20
Idera Pharmaceuticals Announces New U.S. Patent Coverage for Tilsotolimod Through September 2037
8:50am
424B5
zbghs4 5gy
3 Sep 20
Prospectus supplement for primary offering
8:26am
424B5
6yvjuh0 pyfd
2 Sep 20
Prospectus supplement for primary offering
5:20pm
8-K
EX-99.1
l586mp52u20
4 Aug 20
Idera Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate Update
4:31pm
8-K
EX-99.1
8xr6hs4h
15 Jul 20
Idera Pharmaceuticals Announces Private Placement of up to $20.0 Million
8:15am
8-K
EX-99.1
5siotrv pv8
2 Jun 20
Regulation FD Disclosure
8:33am
8-K
EX-99.1
qp7csb n2f9hw9
1 May 20
Idera Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update
8:10am
8-K
EX-99.1
i7c3c3l gpp
21 Apr 20
Idera Pharmaceuticals Announces Final Clinical Safety and Efficacy Data from ILLUMINATE-204 Trial in Advanced Melanoma
8:00am
8-K
EX-99.1
znuxams8ex 9t9gjoh
7 Apr 20
Idera Pharmaceuticals Announces Private Placement of up to $20.7 Million
4:30pm
8-K
EX-99.1
i8lynb
12 Mar 20
Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
7:49am
8-K
EX-99.1
jb270
5 Mar 20
Regulation FD Disclosure
8:00am